Cellular plasticity as a therapeutic vulnerability: HNF4α is a key target in lung adenocarcinoma

Raymond Ho1,2, Jason C Mills1

  • 1Department of Molecular and Precision Medicine, Penn State College of Medicine, Hershey, Pennsylvania, USA.

Insights

Hepatocyte nuclear factor 4 alpha (HNF4α) drives lung cells to adopt gastric features, promoting resistance to KRAS inhibition. This cellular plasticity mechanism is implicated in invasive mucinous adenocarcinoma (IMA) and suggests new therapeutic targets.

Area of Science:

  • Cellular plasticity
  • Cancer biology
  • Molecular mechanisms of tumorigenesis

Background:

  • Cellular plasticity enables lineage changes for tissue repair but can drive cancer development.
  • Invasive mucinous adenocarcinoma (IMA) arises from lung epithelial cells reprogramming into gastric-like cells.
  • Understanding the molecular drivers of this reprogramming is crucial for therapeutic development.

Purpose of the Study:

  • To elucidate the role of hepatocyte nuclear factor 4 alpha (HNF4α) in lung epithelial cell reprogramming towards gastric identity.
  • To investigate the mechanism by which HNF4α influences transcription factors FOXA1 and FOXA2.
  • To determine HNF4α's impact on resistance to KRAS inhibition and its link to nuclear factor erythroid 2-related factor 2 (NRF2) activity.

Main Methods:

  • Investigated the role of HNF4α in lung epithelial cells.
  • Analyzed the interaction of HNF4α with FOXA1 and FOXA2 transcription factors at gastric gene enhancer loci.
  • Assessed the effect of HNF4α on NRF2 activity and resistance to KRAS inhibition.

Main Results:

  • HNF4α promotes gastric identity in lung epithelial cells.
  • HNF4α restricts FOXA1 and FOXA2 to gastric gene enhancer loci.
  • HNF4α enhances resistance to KRAS inhibition by upregulating NRF2 activity.

Conclusions:

  • HNF4α is a key regulator of cellular plasticity driving lung-to-gastric reprogramming in IMA.
  • The HNF4α-FOXA axis and HNF4α-NRF2 pathway are critical for IMA development and therapeutic resistance.
  • Targeting HNF4α or its downstream pathways may offer novel therapeutic strategies for IMA.

Related Concept Videos

Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Cellular Adaptation IV: Dysplasia and Metaplasia01:24

Cellular Adaptation IV: Dysplasia and Metaplasia

DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Cellular Adaptation III: Hyperplasia01:26

Cellular Adaptation III: Hyperplasia

Hyperplasia is an increase in the number of cells in a tissue or organ due to enhanced cell division. It is an adaptive, controlled response to stimuli such as injury, hormones, or stress, involving mitosis to produce genetically identical cells and support tissue repair and regeneration.Tissue CapacityCertain tissues, including the epidermis, intestinal epithelium, bone marrow, and fibroblasts, have a high potential for hyperplasia. Others, such as bone, cartilage, and smooth muscle, show...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...